- Email: [email protected]
Reportlinker adds US enzymes market
FOCUS reveal that the country’s catalyst output and shipment volume both increased by 1% year on year to 52,729 tonnes and 51,912 tonnes, respectively, in 1H 2010. Stronger raw material prices pushed up shipment value by 18% to Yen 142,026 M ($1.7 bn). Shipment volume of catalysts applied in petrochemical manufacture and polymerization increased 24% and 41%, respectively. Shipment volume of catalysts applied in petroleum refining, which makes up for around 50% of the overall output, dropped 12% to 26,995 tonnes. A table presents catalysts production volume, and shipment value and volume for Jan-Jun 2010. Japan Chemical Web, 9 Sep 2010 (Website: http://www.japanchemicalweb.jp)
ON
C ATA LY S T S
$77 bn. The GAO discovered a lack of system for appeals or feedbacks and inconsistent treatment of applicants on the part of the DOE. Ethanol Producer Magazine, Sep 2010 (Website: http://www.ethanolproducer.com)
US enzyme sales to top $2.8 bn in 2014 US sales of enzymes will go up by 4.8%/y to $2.8 bn in 2014, according to a study carried out by market research firm Freedonia Group. The growth will be driven by increasing use of enzymes in the pharmaceutical sector, and to a lesser extent, for processing cellulosic ethanol. The leading enzyme product type, in terms of sales, will continue to be carbohydrases. Chemical Week, 20 Sep 2010, 172 (22), 4
Companies make progress in cellulosic arena
Reportlinker adds US enzymes market
A number of major cellulosic ethanol producers were awarded funding or otherwise continued with their projects during Jun 2010 and Jul 2010. ICM Inc has received a $25 M grant from the DOE to build and run a cellulosic ethanol pilot plant in St Joseph, MO. ICM plans to revamp an existing pilot unit at the site of LifeLine Food LLC to produce fuel using corn fibre, switchgrass, and energy sorghum as feedstock. Another producer, BlueFire Ethanol Fuels Inc, has finished stage I of the DOE loan guarantee programme and is continuing on to stage II. The company is setting up a 19 M gallon/y plant in Fullton, MA, to make ethanol from cellulosic waste such as woody biomass and mill residue using a $230 loan guarantee from the DOE. Fiberight LLC aims to bring online its second municipal solid waste-to-ethanol demonstration plant at the end of Aug 2010. The second demo plant will be built in Lawrenceville, VA, at the same site of the company’s pilot plant. A US Governmental Accountability Office (GAO) report released in late Jul 2010 revealed that flaws with the US DOE Loan Guarantee Program is one of the factors for the slower-thanprojected development of cellulosic capacity. The DOE had only released one loan guarantee worth $535 M as of Apr 2010 and signed nine conditional commitments out of the present loan guarantee authority of
Reportlinker.com announces that a new market research report is available in its catalogue: US Enzymes Market. US demand to increase 5.1%/y through 2014. Demand for enzymes in the US is forecast to rise more than 5%/y to $2.7 bn in 2014. Solid industry growth in recent years has been founded upon advances in higher-value, speciality enzymes used in applications such as pharmaceuticals, research and biotechnology, and biocatalysts, as well as the emerging biofuels market. Going forward, gains will come from continued expansion in these areas as enzyme producers create new niches in the treatment of lysosomal storage disorders (LSDs), the use of biocatalysts in pharmaceutical and fine chemical manufacturing, and in new cellulase formulations enabling biomass-based ethanol refining to reach an economically feasible industrial scale. The nearly double-digit growth in pharmaceutical enzymes seen from 1999 to 2009 was driven by several key enzyme medications holding orphan drug status for treating rare LSDs, most notably imiglucerase for Gaucher’s disease. Along with imiglucerase, key enzyme replacement therapies have included treatments for Hurler syndrome, Fabry disease, and Pompe disease. Pharmaceutical enzymes have also gained ground due to the explosive sales growth of
2
neuromodulators botulinum toxin A and B. Through 2014, the likely approval of new medical indications for neuromodulators and the entrance of new competition for BOTOX in both cosmetic and non-cosmetic applications will shape the prospects for this market segment. Demand for enzymes used in making biofuels has grown strongly as the industry has rapidly scaled up its production capacity and invested in new technology to meet government quotas. To date, enzyme growth in the biofuels market has come largely from alpha amylases and glucoamylases used in conventional starch-based ethanol processing. Gains in the future will be derived from a shift in the product mix toward cellulases and related enzymes needed to refine biomass (cellulosic) ethanol, which is mandated to reach production of 8.5 bn gallons in 2019. Although speciality enzymes are becoming the higher-value segment, industrial enzymes will continue to see stable growth in markets such as pulp and paper processing, animal feed, cosmetics and toiletries, and cleaning products. Market leaders such as Novozymes and Danisco, competing in the industrial segment, will continue to fight off the downward sales pressures coming from commoditization and maturing markets by introducing new, more technical and specially tailored enzymes. In food and beverage applications, novel enzymes are raising beer and wine manufacturing efficiencies, and improving the health profile of fats and oils. The animal feed enzyme market will see moderating benefits from the widespread adoption of phytases as this application matures. In all industrial markets, demand for enzymes will be supported by their more environmentally friendly nature on a variety of levels, including their ability to substitute for harsh chemical solvents. Press release from: Reportlinker, 97, Rue Racine, 69100, Villeurbanne, France. Tel: +33 4 37 37 16 37. Fax: +33 4 37 37 15 56. Website: http://www.reportlinker.com (9 Sep 2010)
The outlook for platinum group metals Nitrogen+Syngas presents its outlook for the precious metals markets and the effect on nitric acid production.
NOVEMBER 2010
ON
C ATA LY S T S
$77 bn. The GAO discovered a lack of system for appeals or feedbacks and inconsistent treatment of applicants on the part of the DOE. Ethanol Producer Magazine, Sep 2010 (Website: http://www.ethanolproducer.com)
US enzyme sales to top $2.8 bn in 2014 US sales of enzymes will go up by 4.8%/y to $2.8 bn in 2014, according to a study carried out by market research firm Freedonia Group. The growth will be driven by increasing use of enzymes in the pharmaceutical sector, and to a lesser extent, for processing cellulosic ethanol. The leading enzyme product type, in terms of sales, will continue to be carbohydrases. Chemical Week, 20 Sep 2010, 172 (22), 4
Companies make progress in cellulosic arena
Reportlinker adds US enzymes market
A number of major cellulosic ethanol producers were awarded funding or otherwise continued with their projects during Jun 2010 and Jul 2010. ICM Inc has received a $25 M grant from the DOE to build and run a cellulosic ethanol pilot plant in St Joseph, MO. ICM plans to revamp an existing pilot unit at the site of LifeLine Food LLC to produce fuel using corn fibre, switchgrass, and energy sorghum as feedstock. Another producer, BlueFire Ethanol Fuels Inc, has finished stage I of the DOE loan guarantee programme and is continuing on to stage II. The company is setting up a 19 M gallon/y plant in Fullton, MA, to make ethanol from cellulosic waste such as woody biomass and mill residue using a $230 loan guarantee from the DOE. Fiberight LLC aims to bring online its second municipal solid waste-to-ethanol demonstration plant at the end of Aug 2010. The second demo plant will be built in Lawrenceville, VA, at the same site of the company’s pilot plant. A US Governmental Accountability Office (GAO) report released in late Jul 2010 revealed that flaws with the US DOE Loan Guarantee Program is one of the factors for the slower-thanprojected development of cellulosic capacity. The DOE had only released one loan guarantee worth $535 M as of Apr 2010 and signed nine conditional commitments out of the present loan guarantee authority of
Reportlinker.com announces that a new market research report is available in its catalogue: US Enzymes Market. US demand to increase 5.1%/y through 2014. Demand for enzymes in the US is forecast to rise more than 5%/y to $2.7 bn in 2014. Solid industry growth in recent years has been founded upon advances in higher-value, speciality enzymes used in applications such as pharmaceuticals, research and biotechnology, and biocatalysts, as well as the emerging biofuels market. Going forward, gains will come from continued expansion in these areas as enzyme producers create new niches in the treatment of lysosomal storage disorders (LSDs), the use of biocatalysts in pharmaceutical and fine chemical manufacturing, and in new cellulase formulations enabling biomass-based ethanol refining to reach an economically feasible industrial scale. The nearly double-digit growth in pharmaceutical enzymes seen from 1999 to 2009 was driven by several key enzyme medications holding orphan drug status for treating rare LSDs, most notably imiglucerase for Gaucher’s disease. Along with imiglucerase, key enzyme replacement therapies have included treatments for Hurler syndrome, Fabry disease, and Pompe disease. Pharmaceutical enzymes have also gained ground due to the explosive sales growth of
2
neuromodulators botulinum toxin A and B. Through 2014, the likely approval of new medical indications for neuromodulators and the entrance of new competition for BOTOX in both cosmetic and non-cosmetic applications will shape the prospects for this market segment. Demand for enzymes used in making biofuels has grown strongly as the industry has rapidly scaled up its production capacity and invested in new technology to meet government quotas. To date, enzyme growth in the biofuels market has come largely from alpha amylases and glucoamylases used in conventional starch-based ethanol processing. Gains in the future will be derived from a shift in the product mix toward cellulases and related enzymes needed to refine biomass (cellulosic) ethanol, which is mandated to reach production of 8.5 bn gallons in 2019. Although speciality enzymes are becoming the higher-value segment, industrial enzymes will continue to see stable growth in markets such as pulp and paper processing, animal feed, cosmetics and toiletries, and cleaning products. Market leaders such as Novozymes and Danisco, competing in the industrial segment, will continue to fight off the downward sales pressures coming from commoditization and maturing markets by introducing new, more technical and specially tailored enzymes. In food and beverage applications, novel enzymes are raising beer and wine manufacturing efficiencies, and improving the health profile of fats and oils. The animal feed enzyme market will see moderating benefits from the widespread adoption of phytases as this application matures. In all industrial markets, demand for enzymes will be supported by their more environmentally friendly nature on a variety of levels, including their ability to substitute for harsh chemical solvents. Press release from: Reportlinker, 97, Rue Racine, 69100, Villeurbanne, France. Tel: +33 4 37 37 16 37. Fax: +33 4 37 37 15 56. Website: http://www.reportlinker.com (9 Sep 2010)
The outlook for platinum group metals Nitrogen+Syngas presents its outlook for the precious metals markets and the effect on nitric acid production.
NOVEMBER 2010